The nation of Zimbabwe has declined a substantial US health deal worth 367 million US dollars (272 million pounds) over five years because of the United States' insistence on confidential data.
The decision came to light after a official document dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson later explained that the US was requesting health data for scientific study and profit but was unwilling to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to secure a deal agreeable to all parties so the country's vital HIV programme can be sustained.
Broader Implications
This rejection follows a comparable situation in Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the security of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had administered assistance for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance openness and responsibility.
As per reports, Sixteen African countries have to date agreed to these new health pacts, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy via American-funded programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the end products would be available to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were disrupting structures already set up through the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This system is intended to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our American counterparts on how future co-operation could be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body stated it acknowledged the official position, but recommended that talks should continue since much of the nation's Aids initiatives relied on external financing.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it said.
The situation underscores the ongoing challenges between receiving crucial international aid and protecting a country's data in an increasingly interconnected world.